Ozempic wave boosts US cobblers and tailors as Americans tighten their belts
US consumers taking weight-loss drugs like Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro have turned to cobblers and tailors as they try to save money while shedding pounds, motivated by a cost-of-living squeeze.